Enoxaparin Sodium Injection, Solution
Product Images NDC 81952-130

Product Visual Gallery

This gallery contains 38 technical images submitted to the FDA as part of the official labeling for Enoxaparin Sodium (NDC 81952-130). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hepalink Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure-a (Figure A)

An instructional illustration labeled 'Figure A' showing two hands preparing a syringe for injection, with arrows indicating the steps to remove or connect a small cap or component of the syringe.*

FDA Label Image

Figure-b (Figure B)

An instructional diagram labeled Figure B showing hands administering a subcutaneous injection using a syringe or prefilled pen device. The illustration highlights the technique of injecting just under the skin, consistent with the subcutaneous route for Enoxaparin Sodium injection.*

FDA Label Image

Figure-c (Figure C)

An instructional diagram labeled Figure C showing a hand holding a prefilled syringe with the needle positioned close to the skin, indicating preparation or administration of a subcutaneous injection.*

FDA Label Image

Figure-d (Figure D)

An instructional line drawing labeled Figure D showing a hand holding a syringe, demonstrating how to position the thumb and fingers to operate or prepare the syringe for use.*

FDA Label Image

Figure-e (Figure E)

An instructional diagram showing a gloved hand disposing of a syringe into a container labeled 'BIOHAZARD.' The image illustrates safe disposal practices for injection equipment, relevant to the subcutaneous injection administration of Enoxaparin Sodium.*

FDA Label Image

Enoxaparin-str1 (Enoxaparin Str1)

Chemical structure of Enoxaparin Sodium showing repeating units with variable groups R1 (H or SO3Na) and R2 (SO3Na or COCH3). The diagram depicts the polysaccharide backbone characteristic of this anticoagulant drug.*

FDA Label Image

Enoxaparin-str2 (Enoxaparin Str2)

Chemical structure diagram of Enoxaparin Sodium, showing its molecular components and arrangement as depicted in the image.*

FDA Label Image

Enoxaparin-fig6 (Enoxaparin Fig6)

A forest plot chart comparing the relative risk of various patient subgroups treated with Enoxaparin Sodium (Enox) versus unfractionated heparin (UFH). The chart lists subgroups by sex, age, infarct location, diabetes status, prior myocardial infarction, fibrinolytic agent used, time to treatment, and PCI status, showing relative risk values and percentages for UFH and Enox, along with the reduction in risk. The overall relative risk favors Enoxaparin.*

FDA Label Image

Enoxaparin-fig7 (Enoxaparin Fig7)

A Kaplan-Meier-type plot displaying hazard distribution function over time (days) to death or myocardial re-infarction for Enoxaparin versus UFH (unfractionated heparin). The graph includes a log-rank test p-value and a smaller inset zooming in on the 1-year data. A risk table is shown below the time axis for both groups.*

FDA Label Image

Instruction-for-us-figure (Instruction For Us Figure)

An instructional diagram depicting the use of a syringe before and after injection. Before use, the syringe includes a plunger rod, needle, and needle cap. After use, the plunger rod is fully depressed, and a protective sleeve covers the needle.*

FDA Label Image

Instruction-for-us-figure-a (Instruction For Us Figure A)

An instructional diagram showing components for administering Enoxaparin Sodium injection. It labels a Lovenox prefilled syringe, a cotton ball or gauze, a sharps disposal container, an alcohol wipe, and a small adhesive bandage, illustrating the items typically used in a subcutaneous injection procedure.*

FDA Label Image

Instruction-for-us-figure-b (Instruction For Us Figure B)

An instructional illustration showing a person peeling or removing a protective backing from a strip or patch, holding an injection pen or syringe in the other hand. The image appears to be guidance on preparing or using a subcutaneous injection device.*

FDA Label Image

Instruction-for-us-figure-c (Instruction For Us Figure C)

An instructional diagram showing a syringe with a black plunger, a transparent barrel, and a needle cap. The syringe is labeled with a section indicating where to find the expiration date. This image is related to the Enoxaparin Sodium injection, solution product.*

FDA Label Image

Instruction-for-us-figure-d (Instruction For Us Figure D)

An illustration showing a syringe filled with a clear liquid labeled as Enoxaparin Sodium injection solution. The syringe is shown with a needle attached, and the liquid is visibly clear inside the barrel, consistent with subcutaneous injection use.*

FDA Label Image

Instruction-for-us-figure-e (Instruction For Us Figure E)

An anatomical illustration depicting the recommended subcutaneous injection sites for Enoxaparin Sodium injection. The shaded areas on the abdomen indicate the preferred locations to administer the injection.*

FDA Label Image

Instruction-for-us-figure-f (Instruction For Us Figure F)

An instructional illustration depicting a hand holding a cleansing swab and preparing to clean the abdominal area above the waistband. This image is associated with the subcutaneous injection of Enoxaparin Sodium.*

FDA Label Image

Instruction-for-us-figure-g (Instruction For Us Figure G)

Instructional illustration showing a person using both hands to remove a needle cap from a syringe filled with Enoxaparin Sodium injection solution. The syringe is held in the right hand, and the cap is being pulled straight off with the left hand, indicated by directional arrows.*

FDA Label Image

Instruction-for-us-figure-h (Instruction For Us Figure H)

An instructional illustration showing a hand holding a pre-filled syringe of Enoxaparin Sodium injection solution. The image demonstrates how to set the dose by adjusting the syringe plunger downward to the desired measurement level.*

FDA Label Image

Instruction-for-us-figure-i (Instruction For Us Figure I)

An instructional diagram showing a hand giving a subcutaneous injection into the abdominal area, specifically below the navel. The image highlights the correct injection site for an Enoxaparin Sodium subcutaneous injection.*

FDA Label Image

Instruction-for-us-figure-j (Instruction For Us Figure J)

A black-and-white instructional illustration showing how to administer a subcutaneous injection. The image depicts a hand holding a syringe at a 90-degree angle to the skin of the abdomen, with an arrow pointing to the injection site and a diagram indicating the correct injection angle.*

FDA Label Image

Instruction-for-us-figure-k (Instruction For Us Figure K)

An instructional diagram showing a hand administering a subcutaneous injection with a syringe to the abdomen. The illustration demonstrates proper injection technique for a subcutaneous injection, with one hand pinching the skin and the other holding the syringe needle at a 90-degree angle to the injection site.*

FDA Label Image

Instruction-for-us-figure-l (Instruction For Us Figure L)

An instructional illustration showing a hand performing a subcutaneous injection into the abdomen area. It depicts the hand positioning the syringe at the injection site near the lower abdomen, with a thumb pinching the skin to create a fold for the injection.*

FDA Label Image

Instruction-for-us-figure-m (Instruction For Us Figure M)

An instructional illustration showing a hand holding an Enoxaparin Sodium prefilled syringe. The diagram highlights a protective sleeve around the syringe and includes an arrow indicating a 'click' action to engage or activate the sleeve mechanism.*

FDA Label Image

Instruction-for-us-figure-n (Instruction For Us Figure N)

An instructional illustration showing a hand placing an Enoxaparin Sodium prefilled syringe into a sharps disposal container. The syringe and needle cap are labeled, emphasizing proper disposal of the injection device after subcutaneous use.*

FDA Label Image

30mg/0.3ml Blister Label (30mg Blister)

Label for Enoxaparin Sodium Injection, USP 30 mg/0.3 mL subcutaneous injection by Hepalink USA Inc. The label indicates the product is a single-dose syringe containing 30 mg enoxaparin sodium injection USP. It includes lot and expiration date fields, storage instructions, a barcode, and the Techdow and Hepalink USA Inc. logos.*

FDA Label Image

30mg Carton Label (30mg Box)

The packaging label for Enoxaparin Sodium Injection, USP shows a 30 mg/0.3 mL dosage strength in subcutaneous injection form. The label states that the package contains ten 0.3 mL single-dose syringes with an automatic safety device. The product is distributed by Hepalink USA Inc. and manufactured by Techdow USA. Storage instructions and warnings are included, along with barcodes and the National Drug Code (NDC) 81952-123-23.*

FDA Label Image

40mg/0.4ml Blister Label (40mg Blister)

Carton label for Enoxaparin Sodium Injection, USP 40 mg/0.4 mL subcutaneous injection. Each single-dose syringe contains 40 mg enoxaparin sodium derived from porcine intestinal mucosa. The label includes lot and expiration date fields, storage instructions at 25°C, distributor information for Hepalink USA Inc., and a barcode. The label features yellow highlight on the strength and dosage, with a red peel here tab on the side.*

FDA Label Image

40mg Carton (40mg Box)

Carton label for Enoxaparin Sodium Injection, USP 40 mg/0.4 mL, a subcutaneous injection. The label states it contains ten 0.4 mL single-dose syringes with automatic safety device. Labeler is Techdow USA, a Hepalink Company. The NDC is 81952-124-24. Storage and handling details, warnings, and distributor information (Hepalink USA Inc.) are printed on the side panel.*

FDA Label Image

60mg/0.6ml Blister Label (60mg Blister)

Label for Enoxaparin Sodium Injection, USP 60 mg/0.6 mL subcutaneous solution in a single-dose syringe. The label includes dosage and administration instructions, storage conditions, and distributor details for Hepalink USA Inc. The label features a barcode, lot and expiration date fields, and a red peel here tab for opening.*

FDA Label Image

60mg Carton (60mg Box)

Packaging label for Enoxaparin Sodium Injection, USP 60 mg/0.6 mL, a subcutaneous injection. The carton contains ten 0.6 mL single-dose syringes with automatic safety devices. Labeler is Techdow USA, a Hepalink company, distributed by Hepalink USA Inc. The label includes storage instructions and regulatory details.*

FDA Label Image

80mg/0.8ml Blister Label (80mg Blister)

Packaging label for Enoxaparin Sodium Injection, USP 80 mg/0.8 mL solution for subcutaneous use. Each single-dose syringe contains 80 mg enoxaparin sodium derived from porcine intestinal mucosa. The label notes storage instructions, distributor Hepalink USA Inc., contact information, and a barcode. The label is repeated multiple times on the sheet with dimensions shown.*

FDA Label Image

80mg Carton (80mg Box)

Package label for Enoxaparin Sodium Injection, USP, 80 mg/0.8 mL solution for subcutaneous use. The label indicates ten 0.8 mL single-dose syringes with automatic safety devices. It is distributed by Hepalink USA Inc. and includes storage instructions and a barcode. The design features a red and white color scheme with black text and the Techdow USA logo.*

FDA Label Image

100mg/1ml Blister Label (100mg Blister)

Label sheet for Enoxaparin Sodium Injection, USP, 100 mg/mL, subcutaneous injection by Hepalink USA Inc. Each label features dosage form, strength, and storage instructions alongside a barcode, lot and expiration fields, and manufacturer contact details. The label includes a red peel tab and the Techdow logo.*

FDA Label Image

100mg Carton (100mg Box)

The packaging label for Enoxaparin Sodium Injection, USP, 100 mg per 1 mL solution for subcutaneous use. It contains ten 1 mL single-dose syringes with automatic safety devices. The label includes the NDC number 81952-130-06 and is distributed by Hepalink USA Inc., with branding by Techdow USA, a Hepalink company. Storage instructions and warnings are also present, alongside barcodes and manufacturing details.*

FDA Label Image

120mg/0.8ml Blister Label (120mg Blister)

Label sheet for Enoxaparin Sodium Injection, USP 120 mg/0.8 mL solution for subcutaneous injection, distributed by Hepalink USA Inc. The label includes dosage information, storage instructions, lot and expiration date fields, a barcode, and a purple highlight for the strength. Multiple copies of the label are arranged on the sheet with dimensions noted.*

FDA Label Image

120mg Carton (120mg Box)

This is the packaging label for Enoxaparin Sodium Injection, USP, 120 mg/0.8 mL, a subcutaneous injection solution. The label indicates the product contains ten 0.8 mL single-dose syringes with an automatic safety device. It is distributed by Hepalink USA Inc. and manufactured by Techdow USA. The label includes storage instructions, a warning to keep out of reach of children, and barcode information.*

FDA Label Image

150mg/1ml Blister Label (150mg Blister)

Label for Enoxaparin Sodium Injection, USP 150 mg/1 mL, a subcutaneous injection supplied as a 1 mL single-dose syringe with an automatic safety device. The label includes usage instructions, storage conditions at 25°C (77°F) with permitted excursions, lot and expiration date fields, distributor information (Hepalink USA Inc.), and barcode. The drug strength is prominently displayed in a purple box.*

FDA Label Image

150mg Carton (150mg Box)

Packaging label for Enoxaparin Sodium Injection, USP 150 mg/1 mL solution for subcutaneous use. The label indicates the product comes in ten 1 mL single-dose syringes with an automatic safety device. It is distributed by Hepalink USA Inc., and the label features the Techdow USA logo. Storage and handling instructions are included, along with the product's NDC 81952-135-06.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.